Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.1M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$34.8M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$33.2M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$30.7M |
| 5 |
DaVita
DVA
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$170M |
| 2 |
STJ
St Jude Medical
STJ
|
+$40.7M |
| 3 |
Danaher
DHR
|
+$37.7M |
| 4 |
Mettler-Toledo International
MTD
|
+$34M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.81% |
| 2 | Consumer Discretionary | 10.65% |
| 3 | Industrials | 10.41% |
| 4 | Healthcare | 10.37% |
| 5 | Technology | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
General Mills
GIS
$21.4B
| $2.21M | 0.07% |
+37,488
| New | +$2.29M |
|
177
Trane Technologies
TT
$99.8B
| $2.21M | 0.07% |
27,205
-5,820
| -18% | -$462K |
|
178
ServiceNow
NOW
$133B
| $2.21M | 0.07% |
126,275
+112,350
| +807% | +$1.96M |
|
179
Mattel
MAT
$4.15B
| $2.21M | 0.07% |
+86,150
| New | +$2.31M |
|
|
JNCE
180
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.2M | 0.07% |
+100,000
| New | +$2.12M |
|
|
AFI
181
DELISTED
Armstrong Flooring, Inc.
AFI
| $2.19M | 0.07% |
119,183
| – | – |
|
182
Vishay Intertechnology
VSH
$4.85B
| $2.18M | 0.07% |
132,373
-26,204
| -17% | -$428K |
|
183
Par Pacific Holdings
PARR
$3.96B
| $2.18M | 0.07% |
131,930
-5,600
| -4% | -$83.6K |
|
184
Alphabet (Google) Class A
GOOGL
$4.22T
| $2.16M | 0.07% |
50,920
+36,920
| +264% | +$1.55M |
|
185
Bio-Rad Laboratories Class A
BIO
$10.2B
| $2.14M | 0.07% |
10,722
-48,378
| -82% | -$9.32M |
|
186
Prothena Corp
PRTA
$485M
| $2.12M | 0.07% |
+38,008
| New | +$2M |
|
187
Voya Financial
VOYA
$8.86B
| $2.11M | 0.06% |
55,604
-10,016
| -15% | -$403K |
|
|
BIG
188
DELISTED
Big Lots, Inc.
BIG
| $2.09M | 0.06% |
42,954
+35,754
| +497% | +$1.8M |
|
|
AYX
189
DELISTED
Alteryx Inc
AYX
| $2.09M | 0.06% |
+133,500
| New | +$2.03M |
|
|
AET
190
DELISTED
Aetna Inc
AET
| $2.08M | 0.06% |
16,335
+6,924
| +74% | +$869K |
|
191
Charter Communications
CHTR
$17.9B
| $2.06M | 0.06% |
+6,307
| New | +$2.01M |
|
192
Camden Property Trust
CPT
$10.8B
| $2.03M | 0.06% |
+25,181
| New | +$2.07M |
|
|
HPP
193
Hudson Pacific Properties
HPP
$787M
| $2.02M | 0.06% |
8,329
-1,062
| -11% | -$262K |
|
|
LEXEA
194
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $2.02M | 0.06% |
44,316
-1,601
| -3% | -$70.4K |
|
|
SFR
195
DELISTED
Starwood Waypoint Homes
SFR
| $1.96M | 0.06% |
57,818
+20,460
| +55% | +$651K |
|
196
Cleveland-Cliffs
CLF
$6.43B
| $1.95M | 0.06% |
237,786
+218,691
| +1,145% | +$2.08M |
|
197
Lincoln National
LNC
$8.07B
| $1.95M | 0.06% |
+29,794
| New | +$2.04M |
|
198
Lowe's Companies
LOW
$121B
| $1.95M | 0.06% |
23,707
-1,293
| -5% | -$99K |
|
199
Boeing
BA
$169B
| $1.95M | 0.06% |
11,000
-19,891
| -64% | -$3.39M |
|
200
Herbalife
HLF
$1.33B
| $1.93M | 0.06% |
66,456
+45,872
| +223% | +$1.28M |
|
Similar funds
Paul Tudor Jones's Q1 2017 Portfolio in Review
As of Q1 2017, Paul Tudor Jones held 1,687 positions worth $3.25B, down 16% from $3.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Paul Tudor Jones withdrew a net $793M in Q1 2017, closing 340 positions and reducing 514 holdings. Its most notable exit was St Jude Medical, an estimated $40.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Paul Tudor Jones opened a new position in iShares MSCI Emerging Markets ETF worth $72.8M.
- Paul Tudor Jones's largest Q1 2017 buy was iShares MSCI Emerging Markets ETF: 1,847,000 shares worth $72.8M.
- Paul Tudor Jones added most to Mead Johnson Nutrition Company in Q1 2017, an estimated $30.7M increase.
- Paul Tudor Jones's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $170M.
- Paul Tudor Jones fully exited St Jude Medical in Q1 2017, selling an estimated $40.7M.
- Paul Tudor Jones's ten largest holdings make up 31% of its $3.25B portfolio in Q1 2017.
- Paul Tudor Jones opened 332 new positions and closed 340 in Q1 2017.
- Paul Tudor Jones's portfolio value fell 16% quarter-over-quarter to $3.25B.
Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.